Role of homoeopathic medicine in cases of glaucoma

Prospective interventional study to explore the efficacy of homoeopathic medicines in Glaucoma using the Glaucoma quality of life-15 (GQL-15) questionnaire - NIL

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063334

Enrollment

Registered

2024-02-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H400- Glaucoma suspect

Interventions

Intervention1: Homoeopathic Constitutional medicine mentioned as below Spigelia, Gelsemium, Belladonna etc.: Homoeopathic medicine will be given orally in either 30, 200 or 1M potency two/ three times

Eligibility

Inclusion criteria

Inclusion criteria: Cases pre-diagnosed or with clinical presentation of Glaucoma will be selected irrespective of age and gender.

Exclusion criteria

Exclusion criteria: Acute congestive glaucoma which require surgical intervention.

Design outcomes

Primary

Measure	Time frame
To study the effectiveness of individualized Homoeopathic medicines in the management of Glaucoma Timepoint: Cases will be evaluated at baseline and at the end of 3 months/12 weeks treatment	—

Secondary

Measure	Time frame
To study the utility of Kent repertory in Glaucoma Timepoint: 1 year	—

Countries

India

Contacts

Public ContactDR RAJENDRA PATEL

PARUL UNIVERSITY

jhpatel2003@gmail.com9909949211

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026